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Abstract
Background: Hyperkinetic dysarthria is characterized by abnormal involuntary movements affecting respiratory, phonatory, and articulatory structures impacting
speech and deglutition. Speech–language pathologists (SLPs) play an important role in the evaluation and management of dysarthria and dysphagia. This review describes
the standard clinical evaluation and treatment approaches by SLPs for addressing impaired speech and deglutition in specific hyperkinetic dysarthria populations.
Methods: A literature review was conducted using the data sources of PubMed, Cochrane Library, and Google Scholar. Search terms included 1) hyperkinetic
dysarthria, essential voice tremor, voice tremor, vocal tremor, spasmodic dysphonia, spastic dysphonia, oromandibular dystonia, Meige syndrome, orofacial, cervical
dystonia, dystonia, dyskinesia, chorea, Huntington’s Disease, myoclonus; and evaluation/treatment terms: 2) Speech–Language Pathology, Speech Pathology, Evaluation,
Assessment, Dysphagia, Swallowing, Treatment, Management, and diagnosis.
Results: The standard SLP clinical speech and swallowing evaluation of chorea/Huntington’s disease, myoclonus, focal and segmental dystonia, and essential vocal
tremor typically includes 1) case history; 2) examination of the tone, symmetry, and sensorimotor function of the speech structures during non-speech, speech and
swallowing relevant activities (i.e., cranial nerve assessment); 3) evaluation of speech characteristics; and 4) patient self-report of the impact of their disorder on activities of
daily living. SLP management of individuals with hyperkinetic dysarthria includes behavioral and compensatory strategies for addressing compromised speech and
intelligibility. Swallowing disorders are managed based on individual symptoms and the underlying pathophysiology determined during evaluation.
Discussion: SLPs play an important role in contributing to the differential diagnosis and management of impaired speech and deglutition associated with hyperkinetic
disorders.
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Introduction
Speech disorders arising from abnormal activity affecting the cortico-
basal ganglia-thalamocortical circuitry causing involuntary movements
are broadly classified as hyperkinetic dysarthria.1–6 Hyperkinetic
dysarthria is generally characterized by abnormal voice, resonance,
speech sound production, and prosody that may impact intelligibility.1,2,7
The involuntary movements that are characteristic of hyperkinetic
dysarthria significantly impact communication, deglutition, and quality
of life.1,2,8–14 Approximately 5–7% of adult patient referrals to speech–
language pathologists (SLPs) are represented by individuals with
voice and motor speech disorders.15,16 Within the Speech Patho-
logy program in the Department of Neurology at Mayo Clinic in
Rochester, MN, the prevalence of individuals diagnosed with motor
speech disorders (i.e., those diagnosed with dysarthria or apraxia of
speech) from 1993 to 2008 was estimated at 57%.7 Within the latter
group, hyperkinetic dysarthria represented approximately 20% of
individuals diagnosed with dysarthria.7 The role of the SLP is to
contribute to the diagnosis and management of impaired commu-
nication and deglutition of this population as part of a multi-
disciplinary team.16
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The standard SLP speech and swallowing evaluation includes
1) case history; 2) examination of the tone, symmetry, and sensorimotor
function of the speech structures (see Figures 1 and 2) during non-
speech, speech and deglutition activities (i.e., cranial nerve assess-
ment); 3) evaluation of speech characteristics; and 4) patient self-
report of the impact of their disorder on activities of daily
living.1,2,7,17–20 Additional evaluation approaches may be incorpo-
rated to further characterize concomitant communication disorders
(e.g., other dysarthria types, language and cognitive disorders) and
inform the differential diagnosis.1,2,7,17,19 The SLP also provides
behavioral modifications that improve communication and degluti-
tion function.1,7,17,21,22 SLP management of dysarthria generally
addresses respiratory, voice, resonance, articulation, or speaking
patterns to improve intelligibility and comprehensibility.7,11,21,23,24
Augmentative and alternative communication approaches may also
be used.17,25 Abnormal deglutition, or dysphagia, is managed based
on the pathophysiology identified during the evaluation.7,8,26,27
The purpose of this review is to describe the standard SLP approach
to evaluation and treatment of hyperkinetic dysarthria and associated
dysphagia. The characteristics of hyperkinetic dysarthria populations
frequently seen by SLPs will be described including patients with
chorea/Huntington’s disease, myoclonus, focal and segmental dysto-
nia, and essential vocal tremor.
Methods
A review of the literature was conducted using PubMed, EBSCO
academic search, Web of Science Core Collection, Google Scholar,
Library of Congress, and the American Speech-Language-Hearing Assoc-
iation (ASHA) online professional practice documents. Only publications
considered relevant to current SLP clinical evaluation and treatment of
individuals with hyperkinetic dysarthria were retrieved. A search was con-
ducted for publications containing specific disorder-based terms including
1) hyperkinetic dysarthria, essential voice tremor, voice tremor, vocal
tremor, spasmodic dysphonia, spastic dysphonia, oromandibular dystonia,
Meige syndrome, orofacial, dystonia, chorea, Huntington’s disease, myo-
clonus, and clinical evaluation; and treatment terms including 2) speech–
language pathology, speech pathology, evaluation, assessment, dysphagia,
swallowing, treatment, and management. Only references written in
Figure 1. Components of a speech motor evaluation. This figure describes the typical activities associated with the case history, quality of life self-report,
and motor speech assessment (oral mechanism and speech assessment portions).
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English between November 1968 and June 2017 were included. A total of
186 references were identified of which those directly addressing speech
and deglutition and speech–language pathology evaluation and treatment
with relevant hyperkinetic dysarthria populations, or commonly used
speech and dysphagia evaluation tools and treatment options, were
selected for this review resulting in a total of 159 references.
This review is organized to describe 1) the typical SLP speech evalua-
tion completed with individuals with hyperkinetic dysarthria; 2) clinical
and instrumented approaches for evaluating dysphagia; 3) general
treatment approaches for dysphagia and dysarthria; and 4) specific
characteristics and unique clinical approaches for evaluating and treating
each of the highlighted hyperkinetic dysarthria populations.
Speech evaluation of hyperkinetic dysarthria
Case history
The SLP evaluation is influenced by several factors acquired dur-
ing the case history. SLPs frequently observe abnormal movements
associated with posture, orofacial, speech patterns, or gait in those with
hyperkinetic dysarthria. During the case history discussion, questions
are posed to elicit the patient’s perspective regarding their involuntary
abnormal movements. Of particular interest are factors that modulate
the involuntary movements associated with the patient’s perception of
increased or lessened effort levels during speaking.7 Individuals are
often aware of difficulty speaking, chewing, or swallowing but unaware
of abnormal movements triggered by volitional activities.7 Patients
may report a sense of tightness and difficulty controlling the move-
ments of specific structures or their voice. Of critical importance are
specific conditions that improve or eliminate the unwanted movements
or improve the quality of speech in those with hyperkinetic dysarthria.
This kind of information can distinguish those with hyperkinetic
dysarthria from other forms of dysarthria or functional speech dis-
orders. For example, speakers with either oromandibular dystonia or
functional speech disorders may report that their speech is normal
for the first few minutes after awakening in the morning followed
by deterioration throughout the day. However, individuals with
Figure 2. Mid-sagittal view of the speech structures. The speech structures shown in this figure are involved in breathing, articulation and resonance during
speech and voice production. The speech structures include the tongue, jaw, lips, larynx, soft palate, and pharynx (i.e. pharyngeal wall).
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functional speech disorders often exhibit worsening of abnormal
movements and disrupted speech during structured assessment
tasks (e.g., sentence or paragraph reading, sustained phonation
as described below) compared with conversational speech. In
contrast, speakers with dystonia, including spasmodic dysphonia,
may demonstrate improvement in symptoms, such as reduc-
tion of laryngeal tension, during sustained phonation compared
to connected speech (e.g., conversation, oral reading). In general,
speakers with hyperkinetic dysarthria typically describe a sensation
of ‘‘tightening’’ in the affected muscles or structures associated
with abnormal movements that is beyond their control. Speakers
with functional disorders report a similar sense of tightening, but
also describe their movement disorder as associated with paralysis,
numbness, or heaviness.
Quality of life self-report instruments
The case history portion of the speech evaluation is supplemented
by administration of a quality of life (QOL) self-report instrument.28
QOL instruments provide an estimation of the degree to which the
disorder impacts the individual’s participation in activities of daily
living. Several instruments are available to determine the QOL impact
of dysarthria and associated voice problems (see Table 1).29–36
Information obtained from selected instrument(s) can inform SLP
evaluation tasks and management goals.
Motor speech evaluation
The motor speech evaluation (Current Procedural Terminology
(CPT) 92522) includes evaluation of the speech structures and their
function to inform diagnostic impressions and management planning.
The motor speech evaluation includes examination of the tone,
symmetry, and function of speech structures during non-speech and
speech activities.1,2,6,7,37 Formal instruments are available to SLPs to
facilitate systematic evaluation and guide differential diagnosis of
dysarthria types.37,38 However, SLPs with expertise in motor speech
disorders can implement systematic evaluation of respiration, articula-
tion, voicing, resonance, and prosody using clinical methods developed
nearly 40 years ago.1,2,7 Table 2 provides a simplified overview of the
auditory–perceptual features used to classify each type of dysarthria
based on the work of Darley, et al.1,2 The motor speech evaluation
may also identify impairments likely to cause dysphagia.7,14,17
The core components of a motor speech evaluation include exami-
nation of the oral mechanism and speech assessment. Examination of
the oral mechanism (see Figure 1) entails observation of speech structure
symmetry, tone, strength, range, and speed of volitional non-speech
movements, including reflex testing elucidating reduced cortical pathway
inhibition of primitive reflexes such as the jaw jerk, snout, sucking,
and palmomental reflexes, or reduced/absent presence of the gag
and cough reflexes typically present in adults.6,7,39,40 Motor speech
testing evaluates speech behaviors under varied conditions to determine
1) respiratory–phonatory coordination during sustained voicing of
vowels, 2) diadochokinesis testing of ‘‘speech-like’’ movements during
rapid single, double, and multisyllabic utterance repetition (alternate
motion rate, or AMR (repetition of a single syllable such as ‘‘puh-puh-
puh…’’ or ‘‘tuh-tuh-tuh…’’ or ‘‘kuh-kuh-kuh…’’) and sequential motion
rate, or SMR (repetition of syllable sequences such as ‘‘puh-tuh-kuh…’’),
and 3) speech characteristics during production of single words, sentence
and paragraph reading, and conversation.1,2,6,7 Auditory–perceptual
impressions are formed during these tasks regarding voice quality (e.g.,
strained, rough, breathy), resonance (e.g., hypernasal, hyponasal), arti-
culatory precision, prosody (e.g., speaking tempo, syllabic stress, pitch,
and loudness variation), intelligibility, and comprehensibility.1,2,7,17,41
Intelligibility refers to the ability of a listener to understand a speaker
based solely on acoustic signal information.23,42–44 Comprehensibility
reflects the level of listener understanding of information shared by the
speaker based on a combination of visible and contextual informa-
tion paired with the acoustic signal.17,45,46 Another measure related to
intelligibility is communication efficiency, or the rate by which an indi-
vidual can successfully convey information to listeners.41 Intelligibility
can be informally reported from the speech motor evaluation,44,47 or
quantified using standardized tools.42,48 The observations made during
the motor speech evaluation enable the SLP to determine the presence/
absence and type and severity of dysarthria.
General motor speech patterns of hyperkinetic dysarthria
The characteristics of hyperkinetic dysarthria vary considerably
across patients. The nature and timing of abnormal speech structure
movements as well as strategies used by the speaker to control abnormal
movements can be gleaned from speech production characteristics.
Interestingly, affected speech structures exhibit normal strength as well
as speed and range of motion, though involuntary movements may
occur symmetrically, asymmetrically, or unilaterally.1,2,6,7 Commonly
observed speech patterns in those with hyperkinetic dysarthria include
unexpected variations in pitch or loudness, inappropriate pauses,
constant or intermittent dysphonia, constant or intermittent hyper- or
hyponasality, articulatory imprecision, and slow speaking rate due to
frequent or extended pause durations.1,2,7,8,20,49–63
The sustained voicing task elucidates minor variations in vocal tract
configuration in those with hyperkinetic dysarthria. For example, vocal
unsteadiness and tremor can be perceived, as can subtle unintended
articulatory movements associated with production of the vowel,
‘‘ah’’.1,64–70 In addition, oscillation of the jaw, soft palate, tongue,
larynx, or pharyngeal wall is reflected by involuntary rhythmic voice
modulations during sustained voice production. Respiratory muscu-
lature may also produce rhythmic or sudden involuntary muscular
contractions affecting loudness levels during sustained voicing and
speech tasks. Abrupt or unpredictable distortions of vowel produc-
tion may implicate dystonic, or choreiform contractions affecting the
respiratory system or articulators.
In summary, the motor speech evaluation is critical for differential
diagnosis of hyperkinetic dysarthria and other dysarthria types. The
hallmark feature of hyperkinetic dysarthria is the presence of
involuntary movements. Table 3 provides a summary of the typical
characteristics associated with each of the forms of hyperkinetic
dyarthria reviewed in this paper. Although involuntary movements are
Barkmeier-Kraemer JM, Clark HM SLP Management of Hyperkinetic Disorders
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not typical of other dysarthria types, speech features may overlap
across more than one type of dysarthria (see Figure 3). This requires
the SLP to carefully consider the entirety of case history, self-
report and motor speech evaluation outcomes to differentially
diagnose individuals. Further, the identification of a specific type
of dysarthria, with or without concomitant language and cogni-
tive deficits, provides a differential diagnosis indicative of specific
neurologic pathology.1,2,6,7
Swallowing evaluation
Evaluation of deglutition in those with hyperkinetic dysarthria
begins during the motor speech evaluation. When dysphagia signs and
symptoms are identified, additional testing methods are required to
determine the pathophysiology of the individual’s dysphagia issues for
optimal management. This section describes the process for evaluating
dysphagia in adults recommended by ASHA (see Figure 4).26,27,71–76
Screening
Individuals suspected of dysphagia are typically referred to a SLP for
screening, or for evaluation of dysphagia complaints.77 The screening
process determines the likelihood that an individual is at risk for
dysphagia and determines whether additional evaluation is needed to
define the nature and severity of the problem. A dysphagia screening
can be conducted by interview, questionnaire, or a brief swallowing
Table 1. Examples of Instruments Developed to Evaluate the Impact of Dysarthria or Voice on Quality of Life
Quality of Life Instruments
for Dysarthria and Voice
General Description Reference
Dysarthria Impact Profile
48 statements are rated on a 5-point scale (1 5 strongly agree to
5 5 strongly disagree) that reflect 5 aspects of dysarthria impact:
1) The effect of dysarthria on the person, 2) Acceptance of dysarthria,
3) How the individual feels when others react, 4) Impact on
communication with others, and 5) Other worries and concerns
Walshe et al.29
Living with dysarthria
50 statements divided across 10 sections of possibly impact
that are rated from 1 (totally disagree) to 6 (fully agree)
Hartelius et al.30
QOL for the dysarthric speaker
questionnaire (QOL-DyS)
40-item instrument in which each statement is rated from 0 (never)
to 4 (always) across the domains of speech characteristics, situational
difficulty, compensatory strategies, and perceived reactions of others.
Piacentini et al.31
Voice Handicap Index
30-item statements that are rated on a 5-point scale (0 5 never to
4 5 always) addressing 3 subscales of physical, functional and
emotional impact of the voice problem on daily life activities
Jacobson et al.32
Voice-Related Quality of Life
(V-RQOL)
10 statements are rated on a 5-point scale from 1 (none, not a problem)
to 5 (problem is as ‘‘bad as it can be’’) regarding voice function over the
past 2 weeks. A standard score is then calculated across each domain of
social-emotional, physical functioning, and total score
Hogikyan et al.33
Voice Activity and Participation
Profile (VAPP)
Uses a 10-cm visual analog scale to judge the degree to which the
individual is affected as described in each of 28 statements (left side of
line indicates never affected and right side represents always affected).
Statements represent such aspects of voice use as Effect on the job,
daily communication, social communication, and emotion
Ma and Yiu34
Voice Symptom Scale (VoiSS)
44-question items rated on a 5-point scale from 1 (never) to 5 (all the time).
Items are linked to five domains including communication problems,





The short form version of this instrument includes 10 question items rated
on a scale from 0 (very much) to 3 (not at all). Items reflect the degree the
individual experiences interference with participation in various situations
due to their disorder
Baylor et al.36
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assessment by a trained professional (e.g., SLP, Registered Nurse (RN),
Licensed Practical Nurse (LPN)).27,77
Clinical evaluation of swallowing
Individuals failing the dysphagia screen undergo a clinical evaluation of
swallowing by the SLP during which the following components are
completed: 1) case history, 2) sensorimotor cranial nerve assessment
relevant to the aerodigestive structures involved in swallowing (i.e.,
cranial nerves I, V, VII, IX, X, XI, XII), 3) patient self-report of
function, severity, and emotional impact of dysphagia on activities
of daily living, 4) evaluation of deglutition with and without food
administration that is systematically varied by volume, consistency,
and temperature as related to reported difficulties, and 5) evaluation of
eating safety and strategies associated with modified diet, swallowing
postures and maneuvers.26,27,72,78
Based on the findings of the clinical evaluation of swallowing, the
SLP may be able to recommend a management plan to address signs
and symptoms of dysphagia. The SLP might also recommend addi-
tional instrumental evaluation (e.g., videofluoroscopic swallow study
[VFSS], flexible endoscopic evaluation of swallowing [FEES]) or
referral to other specialties (e.g., gastroenterology, dietician, otolar-
yngology, etc.).27,71–74 The clinical evaluation of swallowing informs
final conclusions regarding the nature and severity of the dysphagia.
Observations from the clinical evaluation further suggest specific
management strategies for improving swallowing function. The stra-
tegies can be applied during instrumental assessment to determine
their effectiveness for any specific patient.27,71,73,74,79,80
Instrumental evaluation using FEES and VFSS
The most common instrumental approaches used by SLPs to
evaluate dysphagia include FEES and VFSS. Manometry and ultra-
sound can also be utilized in some cases.81,82 The FEES approach to
evaluating deglutition offers a direct observation of the pharyngeal
structures during eating.27,74–76,83 This examination can be conducted
at bedside in acute and inpatient hospital contexts, or in an outpatient
clinic.74,83–86 The advantage of the FEES evaluation is the absence of
radiation exposure and the ability to directly observe the bolus
pathway as well as residue amount and location within the pharynx
during a meal.27,71,84,85,87 FEES can also be used as a means of
biofeedback to facilitate improved swallowing and bolus clearance.26
However, FEES does not afford views of the pharynx during the exact
moment of swallow (when the pharynx is maximally constricted) unless
compromised pharyngeal constriction provides a portal for viewing. In
addition, views of the oral cavity are limited to the base of tongue
region, so the SLP must consider information gained during the
clinical exam to infer the integrity of oral bolus management. Finally,
some individuals may not tolerate placement of the endoscope through
the nasal passageway.
The VFSS method entails a coordinated appointment with the SLP
and radiology. Optimally, the SLP executes one of the currently
published standardized protocols to evaluate the oral, pharyngeal, and
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Sensory ‘‘tricks’’ X X X
Involuntary contraction of
anterior neck muscles associated
with the hyoid bone resulting in
‘‘neck tightness’’
X




Involuntary oscillation (tremor) of
the head, tongue, jaw, lips, soft
palate, pharynx, larynx, or
respiratory musculature.
X
Impaired volitional movement of
the jaw (particularly opening or
closing) that can sometimes










Perceived clicking sound during
speaking
X
Intermittent hypernasality X X
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bolus volumes and consistencies.88,89 In addition, swallowing strategies
based upon the clinical evaluation of swallowing findings will be
evaluated for effectiveness. The most common strategies tested during
the VFSS include bolus modifications (e.g., nectar or honey thick
liquids, or liquid swallows following solid boluses), postural adjustments
(e.g., head turn, neck flexion, side lean), and swallowing maneuvers
(e.g., effortful swallow, or the Mendelsohn maneuver during which
















Intermittent breathy voice breaks X
Slow and irregular AMRs X
Variable speaking tempo X
Variable pitch and loudness
patterns during speaking
X X X






Altered resonance X X
Slowed speaking tempo X X
Figure 3. Example of shared speech features by two types of dysarthria. Speech characteristics and physical findings may be shared requiring that the
entire clinical picture of individuals be considered to successfully differentially diagnose each type.
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swallow for ,2 seconds to facilitate clearance of food through the
throat into the esophagus).26 Upon completion of VFSS testing,
a systematic analysis of the recording is recommended to elucidate
the pathophysiology of the dysphagia signs and symptoms and to
inform effective treatment approaches.88,89
SLP treatment of hyperkinetic dysarthria
The SLP utilizes evaluation outcomes to determine optimal behav-
ioral or augmentative and alternative strategies (e.g., hand gestures/
cues [i.e., unaided communication systems], pictures of symbols or
photos, or the use of electronic devices to facilitate communication of
messages [i.e., aided communication systems]) to improve the speaker’s
intelligibility, comprehensibility, and communication efficiency with
particular focus on conditions eliciting the greatest impairment. Several
factors influence recommendations for management of hyperkinetic
dysarthria including the medical etiology of the problem, prognosis for
improvement, level of severity and impact on quality of life, support
from family members or caregivers, environment of the patient (e.g.,
home, assisted living, skilled nursing facility, etc.), and the individual’s
motivation level and personal goals.7 In some cases, medical/surgical
management is recommended for management of specific types of
hyperkinetic dysarthria.7
Common speech treatment approaches
Common SLP behavioral treatment approaches include techniques
that optimize respiratory–phonatory coordination techniques for improved
pitch and loudness control, phrasing, and consistency of sound
production.7,24,90–92 In addition, facilitative speaking strategies may be
Figure 4. Process for identifying and evaluating dysphagia. This figure illustrates the recommended clinical practice pattern for speech-language
pathologist identification and evaluation of individuals with dysphagia.
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used to improve comprehensibility by modifying speaking tempo,
phrase length, and incorporate purposeful pauses during speak-
ing.7,11,17,91,93 Augmentative and alternative communication strategies may be
required to facilitate improved intelligibility and comprehensibility in
more severely affected individuals.17,25,90 Potential speech–language
pathology treatment approaches for addressing impaired function
and coordination of the respiratory, voice or articulatory compo-
nents of speech production are summarized in Table 4. These
Table 4. Speech–Language Pathologist Treatment Approaches to Managing Impaired Respiratory, Voice, and Articulatory Functions in





or coordination for speech
production
Reduced or inconsistent loudness Expiratory muscle strength training
Dramatic reduction in loudness during
a single breath group during speaking
Lee Silverman Speech Treatment (LSVT)
Inhalation appears inadequate, prolonged,
or speaking initiation occurs at unusual locations
within the respiratory cycle, or utterance
Maximum inhalation/exhalation tasks,
or sustained phonation tasks to improve
respiratory/phonatory coordination and
steadiness
Few words or syllables produced per breath group,
runs out of air before taking a breath
Body positioning to optimize breathing and
respiratory efficiency during speaking
Paradoxical movements of the rib cage and
abdomen during breathing or speaking
Accent Method of Voice Therapy
Abnormal posture or movements associated
with volitional respiratory-phonatory coordination
during speaking
Rehearse taking deeper inhalations prior to
speaking and implementing increased
respiratory effort during speaking
Reduced maximum phonation time
(may also indicate impaired voice function)
Rehearse optimal breath groups during
phrasing of spoken utterances
Impaired voice function
Laryngeal relaxation techniques such as easy
voice onset, yawn-sign, chanting, chewing
method
Poor integrity, loudness, and rate of laryngeal
diadochokinesis (e.g., ee-ee-ee-ee)
Laryngeal Manipulation
Accent Method of Voice Therapy
Confidential Voice Technique/Flow Phonation
Hyperadduction of the vocal folds Biofeedback during voicing/speech tasks
Impaired speech function
Articulation therapy
Modify speaking rate (typically encourage slower)
Impaired articulation Speech rhythm techniques
Abnormal speech pattern or rate Delayed auditory feedback
Abnormal resonance (e.g., hypernasality) Direct magnitude production
Augmentative and alternative
communication intervention
Referral for prosthetic device
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treatment approaches currently lack evidence-based outcomes for
treatment of hyperkinetic dysarthria. However, these treatment
approaches were selected based on their ability to address specific
physiologic issues known to impact speech production in those with
hyperkinetic dysarthria as well as publications mentioning their use for
speech–language pathology treatment of dysarthria, in general (see
Table 4).21,24,66,90,91,94–96 For example, the coordination of respiratory
function with speech production is critical to speaking with adequate
loudness and for speech phrasing. Thus, treatment approaches known
to effectively address impaired/weakened respiratory drive and its
coordination with speech production are listed as possible treat-
ment approaches for addressing signs and symptoms associated with
impaired respiratory drive, or coordination for speech produc-
tion.24,66,90,93,94,96 Alternatively, speaking patterns can be directly
modified using speech rhythm techniques, slowing speaking rate,
delayed auditory feedback, or direct magnitude production.17,21,90,91,97
Further, in those with severely impaired speech, alternative and
augmentative approaches can be used.25,98 Finally, those with impai-
red voice function, such as occurs with spasmodic dysphonia and
essential vocal tremor, may benefit from respiratory–phonatory coordi-
nation approaches and other voice therapy treatment approaches listed,
typically supplementary to medical management approaches.66,92,95,99
Common dysphagia treatment approaches
Treatment approaches for dysphagia in those with hyperkinetic
dysarthria are selected to address the underlying pathophysiology
elucidated during the evaluation of deglutition. As with speech treat-
ment options, there is a dearth of literature offering evidence-based
outcomes regarding dysphagia treatment in those diagnosed with hyper-
kinetic dysarthria. Therefore, the most commonly used approaches
for treating dysphagia are listed in Table 3 offering a comprehensive
summary of currently available dysphagia treatment approaches, in
general. Literature describing dysphagia in those with hyperkinetic
dysarthria commonly reports the use of diet modifications to optimize
bolus preparation, cohesive formation and safe clearance during eating
due to oral preparation and bolus transport problems (see Table
5).8,9,26,89,100–104 Another common approach identified in this patient
population is the use of compensatory strategies that modify posturing or
manner of swallowing to improve airway closure and bolus clearance
(see Table 5).8,9,26,89,100,101,104,105 In some cases, exercise approaches can
be utilized to improve muscle strength and structural performance
during mastication and swallowing (see Table 5, indirect treatment).26,27
Adaptations or compensations for improving eating and swallowing
safety as well as cognitive contributions to dysphagia may also be
recommended (see Table 5).26,27
Specific hyperkinetic disorder characteristics
Chorea/Huntington’s disease
Chorea is characterized by quick non-rhythmic involuntary move-
ments at rest or during attempts to sustain a posture.7,57 The incidence
of dysarthria in Huntington’s disease (HD) is estimated at 78%63 to
93%,60 although the prevalence is unknown. Speech features may
fluctuate dramatically.7 For example, speech may be perceived as
intermittently hypernasal, vacillate between a monotone and exces-
sively variable pitch, or vary from a slow to rapid speech tempo.63
These opposing features reflect both the unpredictability of the
abnormal movements affecting speech production as well as the
strategies speakers employ to maximize communicative effectiveness.
Descriptions of hyperkinetic dysarthria accompanying HD sug-
gest that dysphonia and disruptions in prosody are prominent and
most detrimental to intelligibility.18,58,59,61 This includes weak voice,
breathiness, monotone, and voice arrests.15,58–60 Further, shorter
and more variable sustained phonation is often observed during the
motor speech evaluation. In addition, rapid repetition of syllables
(AMRs such as ‘‘puh’’, ‘‘tuh’’, or ‘‘kuh’’) may be irregular in rhythm
and variable in loudness.18 There is preliminary evidence to suggest
that some of the abnormal speech features observed in HD (e.g.,
excessive pitch and loudness variations) are exacerbated by the use
of antipsychotic medication, whereas precision of vowel articulation
may slightly improve with antipsychotic therapy.60 Overall, the seve-
rity of hyperkinetic dysarthria is strongly associated with HD disease
severity.18
Although dysphagia is considered a complication of HD, it has not
been thoroughly studied.10 Primary dysphagia characteristics in those
with HD are associated with disrupted timing, amplitude, and force
of structural movements in the upper aerodigestive tract as well as
from cognitive impairments.9,100–102,106,107 Hyperkinetic features of
dysphagia in HD include rapid, unpredictable tongue movements, and
premature loss of the bolus into the pharynx prior to swallow
initiation.9,100–102,106,107 During swallowing, incoordination between
breathing and swallowing may occur in addition to prolonged laryn-
geal elevation and frequent eructation.9 Cognitive impairments impact
the patient’s ability to compensate for these difficulties and may lead to
high-risk eating behaviors such as taking large bites.102,107
Myoclonus
Palatal myoclonus (PM) is characterized by rapid rhythmic movements
of the velopharynx that remain constant during breathing as well as
during volitional and vegetative movements and sleeping.7,108,109 If the
amplitude of contractions is low, speech may be unaffected. When
movements are larger, the rhythmic contractions may be perceived as
beating vocal tremor during sustained phonation or as intermittent
hypernasality during speaking. Some individuals perceive a clicking
sound in their ear associated with palatal muscle spasms that open and
close the Eustachian tube.110 The rhythmic movements are usually
readily visible during instrumental assessment.10
The abnormal movements of the soft palate may extend to the
pharyngeal and extrinsic laryngeal musculature. In such cases,
dysphagia symptoms may reflect the disruption of airway protection
timing and impaired bolus transit during swallowing.103,105,111 For
example, one case example111 exhibited disruption of breathing
related to rhythmic myoclonic jerks affecting the soft palate and
larynx associated with difficulty swallowing solid and liquid foods. This
individual’s speech and swallowing symptoms were significantly
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alleviated using a pharmacologic treatment, sodium valproate. Other
case examples reported disruption of speech and swallowing due
to rhythmic myoclonic jerks affecting the pharynx and larynx.103,105
In these cases, dysphagia was characterized as difficulty initiating swal-
lowing and aspiration during swallowing105 as well as delayed onset of
swallowing and laryngeal penetration/aspiration of liquids.103 Safe oral
intake for both cases was achieved using compensatory strategies,105 or
diet modifications103 for dysphagia treatment (see Table 5).
Dystonias
Speech affected by dystonia is characterized by involuntary
activation of isolated muscle groups or diffuse disruption of multiple
muscle groups affecting speech production.2,7 Common observations
in dystonia are adventitious movements of the orofacial structures
during rest, specific tasks (e.g., speaking or eating) or during volitional
movements in general. Supporting the diagnosis of hyperkinetic
dysarthria of dystonia are variations in performance across tasks
and response to sensory tricks. Sensory tricks can include a tactile
mechanism (e.g., finger touching the cheek, or chin, or a toothpick
touching the lips, etc.), proprioceptive, or kinesthetic effect (e.g., tilting
of the head, or bite block to limit jaw movements). The SLP can
explore the use of sensory tricks that reduce symptoms and devise
strategies using sensory tricks to facilitate reduced symptoms during
conversations.7
The impact of dystonia on deglutition varies. Speech-induced
dystonias are often suppressed during mastication and have limited
Table 5. Common Speech–Language pathologist Treatment Approaches to Dysphagia
Diet Modification Compensatory Strategies Adaptations/Compensations Indirect Treatment
Regular oral diet Positional strategies Assistance with feeding Progressive resistive
tongue exercises
PO with modification or dietary




Verbal cues Shaker exercises
Water protocol between meals
only (requires oral hygiene)
Head turn to left
or right
Food placement on plate Masako method
Liquids only (broth, nutritional
supplements, milkshakes)







viscosity of thin, nectar,
honey, or spoon thickness)




Puree (specify runny versus
thicker viscosity)
Multiple swallows per bolus Alternate liquids with food Tongue strengthening and
ROM exercises
Soft and moist solids (easy to
chew and easy to digest: avoid
dry, dense, and stringy foods)
Breath hold prior to swallow Reduce rate of eating Lip strengthening exercises
Medication Form may require
modification (e.g., pill, liquid)
Mendelsohn maneuver Add moisture to dry foods
(e.g., gravy, condiments, etc.)
Jaw strengthening and
ROM exercises
NPO Effortful swallow Temperature of food
(specify cold, room, hot)
Hawk exercise
NPO with supplemental intake Audible exhalation after the
swallow
Small and more frequent meals Neck flexion against
resistance in upright position
Supraglottic swallow Oral tongue/finger sweep Jaw depression against
resistance in upright position
Super supraglottic swallow Biofeedback approaches (e.g.,
surface EMG, FEES, etc.)
Abbreviations: EMG, Electromyography; FEES, Flexible Endoscopic Evaluation of Swallowing; NPO, Nil Per Oral; PO, Per Oral; ROM, Range of Motion.
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impact on deglutition. When the movements interfere with deglutition,
weight loss may occur.104 Alternatively, some oral dystonias are
specifically triggered by eating.112 Hyperkinesias can cause abnormal
movements that disrupt timing of airway protection and interfere with
bolus propulsion,8,113 thereby increasing risk of aspiration, malnutri-
tion, and dehydration.
Oromandibular dystonia. Oromandibular dystonia, by strict definition,
affects jaw musculature, with rare involvement of abnormal movements
of the tongue, lips, or soft palate.8,50 Focal dystonias can also affect the
lips, tongue, and soft palate.2,8,50 Oromandibular dystonia (OMD)
accompanied by blepharospasm may be termed Meige’s syndrome.7,114
The hyperkinetic dysarthria accompanying oromandibular dystonia
may be characterized by imprecise articulation, including impaired
co-articulation (i.e., accommodation of speech movements to surround-
ing speech sounds), hypernasality, breathiness, and disrupted fluency.8
Some speakers with oromandibular dystonia accommodate the abnor-
mal movements such that speech disruption is imperceptible, even when
abnormal movements are visible. Unfortunately, the aesthetic effects of
dystonia may limit communicative effectiveness independently of speech
impairment as listeners may avoid looking at the speaker and therefore
miss important nonverbal cues.45 Dysphagia in those with OMD
occurred in 15.6% of a small case series.100 Those with OMD and
dysphagia8,104 exhibit impaired movements of the oral stage of
deglutition affecting oral bolus control during chewing and oral bolus
transport to the pharynx as well as difficulty swallowing solid foods when
pharyngeal involvement occurs. Successful dysphagia management
utilizes pharmacologic treatment approaches (e.g., Botulinum toxin A
injections, antidystonic medications) as well as diet modification and
compensatory swallowing approaches.8,104
Hyoid dystonia. A relatively rare form of dystonia uniquely affects the
hyoid musculature.115 This variation of dystonia is characterized by
speech resonance changes, anterior neck tightness and dysphagia.115
The abnormal contractions in hyoid musculature are typically visible
during evaluation. Hyoid dystonia may occur as a focal dystonia or as
part of the broader cranial dystonias.
Spasmodic dysphonia. Spasmodic dysphonia is a rare type of idiopathic
focal dystonia estimated to affect one in 100,000 dystonia cases50 with
proportionally more females than males affected.116–118 Symptoms
typically begin between 40 and 50 years of age with gradual progres-
sion during the first year before stabilizing119,120 although some
individuals report continued progression of symptoms over time.120
Spasmodic dysphonia is characterized by involuntary spasms isolated
to the laryngeal muscles during speech production resulting in inter-
mittent onset of voice quality changes.118,121 Two primary types of
spasmodic dysphonia are described based on whether the vocal folds
abduct during spasms (abductor spasmodic dysphonia, or AbSD), or adduct
during spasms (adductor spasmodic dysphonia, or AdSD).49,122,123
The majority of individuals with spasmodic dysphonia exhibit
AdSD type symptoms.118,120 AdSD is characterized by spasmodic
over-adduction of the vocal folds associated with production of voiced
speech sounds, or phonemes, resulting in an intermittently strained–
strangled voice quality, or voice stoppage.49,122,123 AbSD is character-
ized by spasmodic over-abduction of the vocal folds associated with
production of voiceless phonemes resulting in prolonged breathy breaks,
or upward pitch breaks during talking.49,122,123 In rare instances, indi-
viduals exhibit symptoms of both types of spasmodic dysphonia referred
to as a mixed-type spasmodic dysphonia.120 Approximately 30–50% of
individuals with spasmodic dysphonia present with a co-occurring vocal
tremor.116,118,120
Individuals with spasmodic dysphonia report increased sense of
effort and inconsistency of their voice symptoms (i.e., intermittent
normal voicing) with worsening under conditions of anxiety or
stress.123–125 Patients may report or exhibit normal voice production
during laughter, crying, yawning, singing, whispering, or shouting.124
During a speech evaluation, spasmodic dysphonia speech patterns
exhibit distinct auditory–perceptual and acoustic patterns of inter-
mittent phoneme-specific voice spasms or voice quality changes during
production of connected speech stimuli such as sentence or paragraph
reading.49,51,53,64,65,121–123,126–128 Current standard speech stimuli
utilized during voice evaluations include sentences loaded with voiced
phonemes (e.g., We mow our lawn all year.) compared with sentences
loaded with voiceless phonemes (e.g., Peter will keep at the peak.).129
A multidisciplinary working group of experts recommended use of a
specific list of sentences to distinguish between AdSD and AbSD in
individuals suspected of having spasmodic dysphonia.123 The sentence
lists were created from speech stimuli presented in a speech drill
workbook by Fairbanks130 that include a concentration of voiceless or
voiced phonemes, respectively.123 A comparison of the patient’s
reported and observed difficulty reading aloud of the voiceless-loaded
or voice-loaded phoneme sentence lists is compared with whispered
reading of the sentences. Individuals exhibiting strained–strangled
voice quality and voice stoppages on voice-loaded phoneme sentences
and improved voice quality during voiceless phoneme sentences
implicate AdSD. In contrast, individuals exhibiting breathy or upward
pitch breaks during reading of voiceless-loaded phoneme sentences
compared with voiced phoneme sentences implicate AbSD. Whispered
speaking is perceived as easier for both sentence lists in those with
spasmodic dysphonia. A second task that distinguishes individuals with
spasmodic dysphonia is determining whether voice quality improves
during shouting compared to typical speaking patterns.123 Finally,
a comparison of voice quality during sustained phonation (e.g., sustained
voicing of ‘‘ah’’ and ‘‘ee’’ vowels) to connected speech tasks (e.g., reading
sentences, or conversation) is important for two reasons.121,123 First,
sustained voicing is the optimal context for identifying a co-occurring
vocal tremor.67,69,116,118,120,121 The second reason is to compare voice
symptom consistency across speech contexts. Individuals showing similar
degrees of strained–strangled voice quality across both sustained
phonation and connected speaking tasks may have a moderate to severe
muscle tension dysphonia (MTD).53,65,121,127,128 In some cases, MTD
may co-occur with spasmodic dysphonia secondary to efforts by the
individual to control their spasmodic dysphonia symptoms.
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In addition to a thorough speech assessment, nasoendoscopic evalua-
tion is recommended to observe pharyngeal and laryngeal speech
structures directly during sustained voicing and connected speech tasks.
Nasoendoscopy enables confirmation of the diagnosis of spasmodic
dysphonia with or without vocal tremor.123,131,132 Uniquely, application
of topical anesthesia during nasoendoscopy with individuals suspected of
having spasmodic dysphonia is not advised, or should only be minimally
applied within the immediate nasal passageways to improve comfort
level during this procedure.123 This recommendation is due to the
sensory changes topical anesthesia imposes on the throat mucosa
potentially facilitating improved speech symptoms during imaging (i.e.,
‘‘sensory trick’’).123 In some cases, the placement of the scope alone may
serve as a ‘‘sensory trick’’ during the examination resulting in improved
voice symptoms. When this occurs, the likelihood of the individual
having a speech dystonia is increased. During nasoendoscopic evalua-
tion, observation of oscillation of speech structures during sustained
voicing compared with intermittent spasm of the vocal folds in the
abductory or adductory plane can be directly observed for improved
diagnostic precision.123,131,132 High-speed imaging, when available, may
also be used to directly observe brief spasmodic changes in the vocal fold
vibratory patterns during sustained voicing that may not be as readily
observed during nasoendoscopic or typical stroboscopic examination.133
In some individuals, the signs and symptoms presented during
a speech evaluation may require additional differential diagnosis
between spasmodic dysphonia and muscle tension dysphonia. In such
cases, a short trial of speech therapy focused on reducing muscle
tension is recommended to elucidate the pathophysiology of voice
symptoms.92 Spasmodic dysphonia will not be cured by speech therapy
in comparison to a significant reduction in symptoms of MTD with
implementation of speech therapy.92,123,134–136 Although speech
therapy does not cure spasmodic dysphonia, speaking strategies for
lessening effortful voicing responses to vocal fold spasms may benefit
the patient’s response to medical management. Thus, a trial of speech
therapy may be beneficial even if symptoms are not resolved.92,95,99,137
The most effective treatment approach for managing the symptoms
of spasmodic dysphonia involves medical management via injection of
botulinum neurotoxin (BTN) into the affected muscles of the larynx by
a laryngologist.120,132,138–144 BTN benefits individuals with spasmodic
dysphonia by inducing a short-term paresis/paralysis localized to the
injected laryngeal musculature by preventing the release of acetylcho-
line from the presynaptic terminal membrane at the neuromuscular
junction.141,145,146 Reduced muscle function onset begins within 6–
72 hours after injection with gradual loss of effect over 3–6 months as the
BTN is broken down by the body’s enzymes. Individuals presenting with
a combination of spasmodic dysphonia and co-occurring vocal tremor
may experience differing responses to BTN injections requiring modified
treatment approaches when speech structures outside of the larynx
exhibit oscillation.131,132,147 Associated with treatment using BTN injec-
tions, individuals with spasmodic dysphonia may experience a period
of side effects during which swallowing problems can arise.138,148–150
Swallowing problems associated with BTN injection typically occur due
to weakened laryngeal closure/airway protection during swallowing with
subsequent choking on liquids.138,148–150 These symptoms typically
resolve within 2-6 weeks (depending on the injected dosage and location)
following BTN treatment as the neurotoxin is broken down. In antici-
pation of these side effects, individuals may be counseled by the SLP to
manage swallowing difficulties during the side effect phase by drinking
small sips of liquid and flexing their neck (i.e., chin tuck) during
swallowing of liquids for improved airway protection.138,148–150
Dysphagia associated solely with spasmodic dysphonia was reported in
one case presentation in the literature.151 This case was characterized
with onset of dysphagia due to pharyngolaryngeal pain and voice
changes associated with difficulty breathing and intermittent aspiration
symptoms.151 No other reports of dysphagia due to spasmodic dysphonia
unrelated to BTN treatment were identified.
Essential vocal tremor
Speech production characterized by involuntary rhythmic modula-
tion of pitch and loudness perceived as a shaky voice (i.e., vocal tremor)
in those with essential tremor is referred to as essential vocal tremor
(EVT).66,152–154 This disorder can occur in 30–40% of individuals with
essential tremor,69,153–155 or may be the primary sign of essential
tremor.54,154 Approximately 90% of those presenting with EVT are
female.54,154 During the case history, some individuals with EVT may
report improved symptoms with ingestion of alcohol similar to the effect
upon limb tremor.54,154 In addition, Voice Handicap Index scores show
comparable scoring across the three subscales of functional, physical,
and emotional impact on activities of daily living, particularly in those
with more severe voice symptoms.156 Individuals with mild EVT may
not exhibit perceptible symptoms during connected speech tasks (e.g.,
reading sentences, or conversation).67,69 However, severe EVT is
characterized by a slowed speaking tempo52 and perception of vocal
tremor during both sustained phonation and connected speech tasks.67,69
Thus, evaluation of EVT across speech contexts is important for
determining severity level.52,67 Further, changes in EVT severity should
be evaluated across different pitch and loudness levels to determine
conditions under which vocal tremor is improved or worsened.66,157
Nasoendoscopy is used to image speech structures of the pharynx
and larynx and identify oscillating structures during speech tasks. This
information is useful for judging the severity of EVT and anticipated
responsiveness to medical management.68,131 Involvement of the
larynx as well as other articulators in the upper airway is associated
with poor treatment outcomes using BTN treatment.68,131 However,
individuals showing mild vocal tremor or the ability to reduce their
voicing duration may be candidates for speech treatment.66,153,158,159
Current speech treatment approaches with EVT are limited to case-
based publications66,153 with one reporting benefit from shortening
voicing duration during speaking combined with improved respira-
tory–phonatory coordination.66 Shortened voicing duration reduces
perception of vocal tremor by disrupting the cyclic modulation of the
voice.66,159 Improved respiratory–phonatory coordination aims to
reduce speech structure muscle tension levels. Thus, methods found
effective in reducing throat and voicing tension include the use of
increased airflow and reduced effort levels during talking.66,159
Barkmeier-Kraemer JM, Clark HM SLP Management of Hyperkinetic Disorders
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services14
Conclusion
Hyperkinetic dysarthria is characterized by abnormal involun-
tary movements affecting respiratory, phonatory, and articulatory
structures significantly impacting communication, deglutition, and
quality of life. Spasmodic dysphonia and essential voice tremor have
been studied more thoroughly than other hyperkinetic speech impair-
ments and are also the disorders for which speech therapy is most often
sought by patients and requested by physicians. Speech therapy may
reduce the impact of hyperkinetic dysarthria on functional commu-
nication and the effort associated with speaking.92,95,99,137 However,
speech therapy does not cure hyperkinetic dysarthria and, as such, is
often paired with the preferred practice of BTN injection in the
management of dystonia and tremor. The risks inherent in BTN
injection for oromandibular, pharyngeal, and laryngeal dystonia
include the potential negative impact on breathing, speech, and
deglutition. Several therapeutic strategies are described in the
literature for managing the impact of speech problems and dysphagia
associated with hyperkinetic dysarthria. However, few studies have
identified the relevant factors predictive of successful treatment out-
comes such as candidacy for specific treatment approaches, optimal
treatment dosage, and cost effectiveness. One challenge to identifying
such important factors is the consultative nature of, and relative rarity
of hyperkinetic dysarthria on the average speech–language pathology
case load. Future research addressing optimal treatment approaches
and important factors predictive of outcomes as well as the incor-
poration of technologic advancements in imaging and physiology
analysis may yield novel methods for the assessment and treatment of
hyperkinetic dysarthria.
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